HK1217642A1 - 合成用於绿脓杆菌疫苗的低聚糖 - Google Patents

合成用於绿脓杆菌疫苗的低聚糖 Download PDF

Info

Publication number
HK1217642A1
HK1217642A1 HK16105605.8A HK16105605A HK1217642A1 HK 1217642 A1 HK1217642 A1 HK 1217642A1 HK 16105605 A HK16105605 A HK 16105605A HK 1217642 A1 HK1217642 A1 HK 1217642A1
Authority
HK
Hong Kong
Prior art keywords
aeruginosa
los
synthetic oligosaccharides
aeruginosa vaccine
oligosaccharides
Prior art date
Application number
HK16105605.8A
Other languages
English (en)
Chinese (zh)
Inventor
A. Stewart Campbell
Obadiah J. Plante
Original Assignee
Visterra Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visterra Inc. filed Critical Visterra Inc.
Publication of HK1217642A1 publication Critical patent/HK1217642A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK16105605.8A 2013-07-03 2014-07-01 合成用於绿脓杆菌疫苗的低聚糖 HK1217642A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361842474P 2013-07-03 2013-07-03
US61/842,474 2013-07-03
PCT/US2014/045057 WO2015002954A1 (en) 2013-07-03 2014-07-01 Synthetic oligosaccharides for p. aeruginosa vaccine

Publications (1)

Publication Number Publication Date
HK1217642A1 true HK1217642A1 (zh) 2017-01-20

Family

ID=52144159

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105605.8A HK1217642A1 (zh) 2013-07-03 2014-07-01 合成用於绿脓杆菌疫苗的低聚糖

Country Status (13)

Country Link
US (1) US20160144016A1 (enExample)
EP (1) EP3016685B1 (enExample)
JP (1) JP2016525507A (enExample)
KR (1) KR20160098161A (enExample)
CN (1) CN105517573A (enExample)
AU (1) AU2014284457A1 (enExample)
CA (1) CA2917192A1 (enExample)
CL (1) CL2015003792A1 (enExample)
HK (1) HK1217642A1 (enExample)
IL (1) IL243432A0 (enExample)
MX (1) MX2016000195A (enExample)
SG (1) SG11201510792XA (enExample)
WO (1) WO2015002954A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017018017A2 (pt) 2015-02-26 2018-04-10 Thevax Genetics Vaccine Co Ltd composição de vacina compreendendo uma proteína imunogênica e adjuvantes de combinação para uso na promoção de respostas de células t específicas de antigenos
CN107827981B (zh) * 2017-11-01 2019-10-25 深圳市国创纳米抗体技术有限公司 抗绿脓杆菌外毒素a的纳米抗体及其应用
CA3160266A1 (en) * 2019-12-04 2021-06-10 University Of Montana Antibacterial carbohydrate vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693891A (en) * 1985-09-09 1987-09-15 Miles Laboratories, Inc. Vaccine for Pseudomonas aeruginosa
EP1479695B1 (en) * 2003-05-14 2010-02-17 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS O6 of Pseudomonas aeruginosa
CN101912609B (zh) * 2009-08-20 2012-02-01 成都蓉生药业有限责任公司 防治绿脓杆菌感染的组合物及其制备方法
WO2011133227A2 (en) * 2010-04-23 2011-10-27 Ancora Pharmaceuticals Inc. Synthetic oligosaccharides for staphyloccocus vaccine
CN101947323B (zh) * 2010-07-26 2013-02-27 北京绿竹生物制药有限公司 一种革兰氏阴性细菌疫苗及其制备方法
WO2012082635A1 (en) * 2010-12-13 2012-06-21 Ancora Pharmaceuticals, Inc. Synthetic oligosaccharide group a streptococcus
EP2554549A1 (en) * 2011-08-02 2013-02-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools
EP2884842A4 (en) * 2012-07-16 2016-04-20 Visterra Inc SYNTHETIC OLIGOSACCHARIDES FOR ANTI-P. aeruginosa

Also Published As

Publication number Publication date
WO2015002954A1 (en) 2015-01-08
JP2016525507A (ja) 2016-08-25
EP3016685A1 (en) 2016-05-11
IL243432A0 (en) 2016-03-31
AU2014284457A1 (en) 2016-01-28
EP3016685A4 (en) 2016-11-23
EP3016685B1 (en) 2018-01-31
CL2015003792A1 (es) 2017-01-20
SG11201510792XA (en) 2016-01-28
US20160144016A1 (en) 2016-05-26
CN105517573A (zh) 2016-04-20
CA2917192A1 (en) 2015-01-08
MX2016000195A (es) 2016-08-18
KR20160098161A (ko) 2016-08-18

Similar Documents

Publication Publication Date Title
ZA201903620B (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2020001138A (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
ZA201807203B (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
MX2016009468A (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
IL246361A0 (en) Antibody conjugates - antidote - trop 2, preparations containing them and their uses
PE20150892A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
WO2015168019A3 (en) Anti-ptk7 antibody-drug conjugates
WO2016094837A3 (en) Anti-c10orf54 antibodies and uses thereof
HUE051728T2 (hu) Konjugált burokszaccharid antigéneket tartalmazó immunogén készítmények és alkalmazásaik
WO2014197849A3 (en) Anti-c10orf54 antibodies and uses thereof
IN2015DN00694A (enExample)
WO2011142858A3 (en) Chlorotoxin variants, conjugates, and methods for their use
WO2015164392A8 (en) Novel anti-rnf43 antibodies and methods of use
MX2015002482A (es) Composicion inmunogenica.
EA033491B1 (ru) Конъюгатные вакцины на основе сальмонеллы
WO2018053552A3 (en) Isoquinolidinobenzodiazepines
ZA201803476B (en) Anti-cd22 antibody-maytansine conjugates and methods of use thereof
EA201592128A1 (ru) Композиция против регургитации для поддерживания перистальтики кишечника
BR112015016033A8 (pt) composições farmacêuticas para tratamento de infecções por bactérias, e seus usos
WO2016198170A8 (en) Vaccines against streptococcus pneumoniae serotype 5
HK1217642A1 (zh) 合成用於绿脓杆菌疫苗的低聚糖
HK1222336A1 (zh) 包含胆硷及其衍生物的组合物、其用途以及其制备方法
WO2015181834A3 (en) Novel semi-synthetic meningococcal conjugate vaccine
HK1211795A1 (en) Synthetic oligosaccharides for p. aeruginosa vaccine
ZA202103644B (en) Multivalent glycoconjugates immunogenic compositions

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAME OF APPLICANT FROM SYNGLYCO PHARMACEUTICALS, INC. TO SYNGLYCO INC.